1
|
Samman PD and White WF: The ‘Yellow Nail’
Syndrome. Br J Dermatol. 76:153–157. 1964.PubMed/NCBI View Article : Google Scholar
|
2
|
Valdés L, Huggins JT, Gude F, Ferreiro L,
Alvarez-Dobaño JM, Golpe A, Toubes ME, González-Barcala FJ, José ES
and Sahn SA: Characteristics of patients with yellow nail syndrome
and pleural effusion. Respirology. 19:985–992. 2014.PubMed/NCBI View Article : Google Scholar
|
3
|
Vignes S and Baran R: Yellow nail
syndrome: A review. Orphanet J Rare Dis. 12(42)2017.PubMed/NCBI View Article : Google Scholar
|
4
|
Hillerdal G: Yellow nail syndrome:
Treatment with octreotide. Clin Respir J. 1:120–121.
2007.PubMed/NCBI View Article : Google Scholar
|
5
|
Glazer M, Berkman N, Lafair JS and Kramer
MR: Successful talc slurry pleurodesis in patients with
nonmalignant pleural effusion. Chest. 117:1404–1409.
2000.PubMed/NCBI View Article : Google Scholar
|
6
|
Symons JA, Wood NC, Di Giovine FS and Duff
GW: Soluble IL-2 receptor in rheumatoid arthritis. Correlation with
disease activity, IL-1 and IL-2 inhibition. J Immunol.
141:2612–2618. 1988.PubMed/NCBI
|
7
|
Takahashi S, Setoguchi Y, Nukiwa T and
Kira S: Soluble interleukin-2 receptor in sera of patients with
pulmonary tuberculosis. Chest. 99:310–314. 1991.PubMed/NCBI View Article : Google Scholar
|
8
|
Dik WA and Heron M: Clinical significance
of soluble interleukin-2 receptor measurement in immune-mediated
diseases. Neth J Med. 78:220–231. 2020.PubMed/NCBI
|
9
|
Watanabe E, Mochiduki Y, Nakahara Y,
Kawamura T and Sasaki S: A case of yellow nail syndrome with
bilateral pleural effusion. Nihon Kokyuki Gakkai Zasshi.
48:458–462. 2010.PubMed/NCBI(In Japanese).
|
10
|
Hokari R and Tomioka A: The role of
lymphatics in intestinal inflammation. Inflamm Regen.
41(25)2021.PubMed/NCBI View Article : Google Scholar
|
11
|
Baran R and Thomas L: Combination of
fluconazole and alpha-tocopherol in the treatment of yellow nail
syndrome. J Drugs Dermatol. 8:276–278. 2009.PubMed/NCBI
|
12
|
Suzuki M, Yoshizawa A, Sugiyama H,
Ichimura Y, Morita A, Takasaki J, Naka G, Hirano S, Izumi S, Takeda
Y, et al: A case of yellow nail syndrome with dramatically improved
nail discoloration by oral clarithromycin. Case Rep Dermatol.
3:251–258. 2011.PubMed/NCBI View Article : Google Scholar
|
13
|
Lotfollahi L, Abedini A, Alavi Darazam I,
Kiani A and Fadaii A: Yellow Nail Syndrome: Report of a case
successfully treated with octreotide. Tanaffos. 14:67–71.
2015.PubMed/NCBI
|
14
|
Maldonado F, Tazelaar HD, Wang CW and Ryu
JH: Yellow nail syndrome: Analysis of 41 consecutive patients.
Chest. 134:375–381. 2008.PubMed/NCBI View Article : Google Scholar
|
15
|
Gaber Y: Diseases of Lymphatics. In:
Braun-Falco´s Dermatology. Plewig G, French L, Ruzicka T, Kaufmann
R, Hertl M (eds). Springer, Berlin, Heidelberg, 2020.
|
16
|
Chrobák L: Clinical significance of
soluble interleukin-2 receptor. Acta Medica (Hradec Kralove).
39:3–6. 1996.PubMed/NCBI
|
17
|
Caruso C, Candore G, Cigna D, Colucci AT
and Modica MA: Biological significance of soluble IL-2 receptor.
Mediators Inflamm. 2:3–21. 1993.PubMed/NCBI View Article : Google Scholar
|
18
|
Ina Y, Takada K, Sato T, Yamamoto M, Noda
M and Morishita M: Soluble interleukin 2 receptors in patients with
sarcoidosis. Possible origin. Chest. 102:1128–1133. 1992.PubMed/NCBI View Article : Google Scholar
|
19
|
Rubin LA and Nelson DL: The soluble
interleukin-2 receptor: Biology, function and clinical application.
Ann Intern Med. 113:619–627. 1990.PubMed/NCBI View Article : Google Scholar
|
20
|
Yamagishi T, Hatanaka N, Kamemura H,
Nakazawa I, Hirano Y, Kodaka N, Miura A, Kitahara A, Sawata T,
Hosaka K and Sanno K: Idiopathic yellow nail syndrome successfully
treated with OK-432. Internal Med. 46:1127–1130. 2007.PubMed/NCBI View Article : Google Scholar
|
21
|
Katsura H, Nakagawa K, Iwasaki T, Tamura M
and Nakane S: Thoracoscopic assisted pleuro-peritoneal shunt
placement procedure for patient having refractory pleural effusion:
A case report of ‘yellow-nail syndrome’. Jpn J Chest Surg.
21:565–570. 2007.(in Japanese).
|
22
|
Mohs Z, DeVillers M, Ziegler S, Basson MD
and Newman W: Management of malignant pleural effusions in U.S.
Veterans: A retrospective review. Ann Thorac Cardiovasc Surg.
28:420–428. 2022.PubMed/NCBI View Article : Google Scholar
|
23
|
Hase I, Kurasawa K, Takizawa H, Yamaguchi
B, Sakuma H and Ishii Y: Hyperplasia of Lymphoid follicles and
lymphangiectasia in the parietal pleura in bucillamine-induced
yellow nail syndrome. Intern Med. 57:1887–1892. 2018.PubMed/NCBI View Article : Google Scholar
|